The utility of [99mTc]HMPAO-leukocytes for imaging infection

Seminars in Nuclear Medicine

Volumn 24, Issue 2, 1994, Pages 110-127

  Peters, A Michael ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; OXIME; TECHNETIUM COMPLEX;

ARTICLE; BONE; ENTERITIS; GASTROINTESTINAL TRACT; HUMAN; INFECTION; LEUKOCYTE; OSTEOMYELITIS; PYREXIA IDIOPATHICA; SCINTISCANNING; THORAX DISEASE;

BONE AND BONES; FEVER OF UNKNOWN ORIGIN; GASTROINTESTINAL SYSTEM; HUMAN; INFECTION; INFLAMMATORY BOWEL DISEASES; LEUKOCYTES; ORGANOTECHNETIUM COMPOUNDS; OSTEOMYELITIS; OXIMES; TECHNETIUM TC 99M EXAMETAZIME; THORACIC DISEASES;

EID: 0028414777     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-2998(05)80226-0     Document Type: Article

References (71)

1. Survey of radioactive agents for in vitro labelling of phagocytic leukocytes. I. Soluble agents
2. Labelling of platelets with oxine complexes of Tc-99m and In-111. I. In vitro studies and survival in the rabbit
3. Tc-99m labelled human leucocytes. An in-vitro functional study
4. Cell labelling with colloidal substances in whole blood
5. Tc-99m autologous phagocyte scanning: A new imaging technique for inflammatory bowel disease
6. Tc-99m labelled porphyrin as an imaging agent for occult infections and inflammation
7. Techniques of leucocyte harvesting and labeling: Problems and perspectives
8. A Tc-99m labelled radio tracer for the investigation of cerebral vascular disease
9. Imaging inflammation with Tc-99m hexamethyl propyleneamineoxime (HMPAO) labelled leucocytes
10. Tc-99m HMPAO labelled leucocytes: Comparison with In-111-tropolonate labelled granulocytes
11. The development of a clinical protocol for the radiolabelling of mixed leucocytes with Tc-99m hexamethylpropyleneamine oxime
12. Splenic pooling of granulocytes
13. The kinetics of 111-indium distribution following injection of 111-indium labelled autologous granulocytes in man
14. Lung transit of 111-indium labelled granulocytes. Relationship to labelling techniques
15. Leukokinetic studies. III. The distribution of granulocytes in the blood of normal subjects
16. Leukokinetic studies II A method of labelling granulocytes in vitro with radioactive diisopropylfluorophosphonate
17. Quantification of the distribution of the marginating granulocyte pool in man
18. Neutrophil kinetics in man
19. Comparison of Tc-99m HMPAO leucocytes with In-111 oxine leucocytes for localising intra-abdominal sepsis
20. Clinical importance of enteric communication with abdominal abscesses
21. The value of In-111-labelled leucocytes in clinical practice
22. Sctintigraphic assessment of bowel involvement and disease activity in Crohn's disease using Tc-99m hexamethylpropyleneamine oxime as a leucocyte label
23. Prospective comparative study of technetium-99m WBCs and indium-111 granulocytes for the examination of patients with inflammatory bowel disease
24. Fast diagnosis of abdominal infections and inflammation with Tc-99m HMPAO labelled leucocytes
25. Indium-111 autologous leucocyte scanning: Comparison with radiology for imaging the colon in inflammatory bowel disease
26. Comparison of simultaneous Tc-99m HMPAO and In-111 oxine labelled white cell scans in the assessment of inflammatory bowel disease
27. Assessment of disease activity in ulcerative colitis using 111-indium labelled leucocyte faecal excretion
28. Quantitative faecal 111-indium leucocyte excretion in the assessment of disease activity in Crohn's disease
29. In-111 whole body retention A new method for quantification of disease activity in inflammatory bowel disease
30. Indium-111 labelled granulocyte accumulation in respiratory tract of patients with bronchiectasis
31. Quantification of disease activity in Crohn's disease by computerised analysis of Tc-99m hexamethylpropyleneamine oxime (HMPAO) labelled leucocyte images
32. Tc-99m HMPAO labelled leucocyte imaging in Crohn's disease; A subtraction technique for the quantification of disease activity
33. Do technetium-99m hexamethypropyleneamine oxime (HMPAO) labelled leukocytes truly reflect the mucosal inflammation in patients with ulcerative colitis?
34. The small bowel enema: A ten year review
35. Ultrasonic assessment of inflammatory bowel disease
36. Air enema revisited in assessment of colitis
37. Gut lavage fluid protein concentrations: Objective measures of disease activity in inflammatory bowel disease
38. Imaging of bone infection with labelled white blood cells: Role of contemporaneous bone marrow imaging
39. The diagnosis of bone infection with In-111 labelled granulocytes
40. In-111 leucocyte scanning in the evaluation of painful arthroplasty
41. Imminoscintigraphy with anti-polymorphonuclear neutrophils—MAB for the diagnosis of septic loosening of hip prothesis
42. Diagnosis of musculoskeletal infection using combined In-111 labeled leukocytes and Tc-99m SC marrow imaging
43. Scintigraphy of inflammation with nonspecific tracers in orthopedic infections
44. Imaging inflammatory and infectious lesions after injection of radioiodinated antigranulocyte antibodies
45. Autologous granulocyte scanning of painful prosthetic joints
46. Bone marrow marginates radiolabelled granulocytes and so need not be separately imaged for the diagnosis of osteomyelitis
47. Cause and significance of cold bone defects on In-111 labeled leucocyte imaging
48. Evaluation of complicating osteomyelitis with Tc-99m MDP, In-111 granulocytes and Ga-67 citrate
49. In-111 labelled granulocyte scanning to detect inflammation in the lungs of patients with chronic sputum expectoration
50. A retrospective study of granulocyte kinetics in patients with systemic vasculitis
51. Mechanics of stimulated neutrophils: Cell stiffness induces retention in capillaries
52. Diffuse pulmonary uptake of In-111 labelled leukocytes in drug-induced pneumonitis
53. Pulmonary granulocyte margination is increased in patients with inflammatory bowel disease
54. Neutrophil-pulmonary interaction in the adult respiratory distress syndrome
55. Pulmonary microvascular alterations and injury induced by complement fragments: Synergistic effect of complement activation, neutrophil sequestration and prostaglandins
56. Fever of undertermined origin: Diagnosis and follow-up of 105 cases, 1970–1980
57. Indium leucocyte scanning in pyrexia of unknown origin
58. The role of indium-labelled leucocyte imaging in pyrexia of unknown origin
59. Imaging with white cells
60. Comparison of Tc-99m HMPAO and In-111 oxine labelled granulocytes in man: First clinical results
61. White cells radio-labelled with In-111 and Tc-99m—A study of relative sensitivity and in vivo stability
62. m-HMPAO-labelled leucocytes in the detection of inflammation
63. Technetium-99m-HMPAO-labeled leukocytes in detection of inflammatory lesions: Comparison with gallium-67 citrate
64. Technetium-99m-HMPAO-labeled leukocytes and technetium-99m-labeled human polyclonal immunoglobulin G in diagnosis of focal purulent disease
65. In-111 labelled non-specific immunoglobulin scanning in the detection of focal infection
66. Scintigraphic detection of bone and joint infection with In-111 labelled non specific polyclonal human immunoglobulin G
67. Experimental studies of 18F-2-fluoro-2-deoxy-D-glucose (FDG) in infections and reactive lymph nodes
68. Technetium-99m-labeled chemotactic peptites: Comparison with indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit